NuCana plc
NuCana plc (NCNA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NCNA · as of Jun 9, 2026
Key Statistics
Explore NuCana plc Data
ncna stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
Competitors & Peers
ncna competitorsNCNA
CASI
CLGN
CLSD
ENLV
GDTCStock Performance
Full HistoryAbout NuCana plc
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platfo…
what is nucana plc · ncna stock overview · nucana plc company profile · who is nucana plc ceo · ncna NASDAQ · nucana plc headquarters · nucana plc business segments
About Stock Overview & Key Data
NuCana plc (NCNA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 28, 2017. As of the latest trading session, NCNA stock price is $2.05, with a market capitalization of $12.4M. The stock has returned -86.55% over the past 12 months and -43.06% year-to-date.
According to 8 Wall Street analysts, the consensus rating for NuCana plc stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, NuCana plc reported revenue of — and net income of -$29.4M. For detailed data — including NuCana plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NuCana plc (NCNA) stock price is $2.05. The stock is traded on NASDAQ under the ticker symbol NCNA. The 52-week range is $1.33 – $40.00.